UNRAVEL BIOSCIENCES
Unravel Biosciences is a therapeutics company spun out from the Wyss Institute at Harvard University that develops new therapeutics for complex disorders by using existing drugs to discover and clinically validate new targets. By integrating a proprietary large action model of human health with rapid in vivo screening and clinical validation of discovered targets, our AI-powered discovery engine uncovers new drug targets for complex disorders and leveraging existing drugs to clinically derisk th... e discovered novel biology 2-3x faster and >10x cheaper than competing approaches. Unravel’s platform has been validated with discoveries that are being translated to 4 clinical trials, and the company has established a wide range of partnerships through its rareSHIFT™ services arm that has resulted in rapid therapeutics pipeline, IP portfolio, and clinical sample expansion while being net profitable.
UNRAVEL BIOSCIENCES
Industry:
Biotechnology Health Care Medical
Founded:
2021-02-19
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.unravel.bio
Total Employee:
1+
Status:
Active
Contact:
510-984-2317
Total Funding:
3.28 M USD
Technology used in webpage:
Squarespace Hosted JotForm
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Fore Biotherapeutics
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Advisors List
Advisor
2022-10-01
Current Employees Featured
Frederic Vigneault Co-Founder and CSO @ Unravel Biosciences
Co-Founder and CSO
2021-11-01
Richard Novak Co-founder and CEO @ Unravel Biosciences
Co-founder and CEO
2021-09-01
Neal Muni CMO @ Unravel Biosciences
CMO
Founder
Investors List
Massachusetts General Hospital
Massachusetts General Hospital investment in Grant - Unravel Biosciences
RTK Group
RTK Group investment in Pre Seed Round - Unravel Biosciences
BoxOne Ventures
BoxOne Ventures investment in Pre Seed Round - Unravel Biosciences
Good Ventures
Good Ventures investment in Pre Seed Round - Unravel Biosciences
KdT Ventures
KdT Ventures investment in Pre Seed Round - Unravel Biosciences
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Non Equity Assistance - Unravel Biosciences
Official Site Inspections
http://www.unravel.bio Semrush global rank: 9.08 M Semrush visits lastest month: 445
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Unravel Biosciences"
Unravel Biosciences - Crunchbase Company Profile
Unravel’s platform has been validated with discoveries that are being …See details»
Unravel Biosciences - BIO International Convention 2025
Unravel Biosciences is a neurology-focused biotech leveraging a deep innovation stack and proprietary transcriptomic datasets. Our AI/ML adaptation computes clinically actionable …See details»
Unravel Biosciences 2025 Company Profile: Valuation, Funding ...
Unravel Biosciences’s primary industry is Drug Discovery. Is Unravel Biosciences a private or public company? Unravel Biosciences is a Private company. What is Unravel Biosciences’s …See details»
Unravel Biosciences – Startups.Bio
Aug 13, 2021 Unravel Biosciences’ initial focus is to accelerate and de-risk the development of effective treatments for patients living with rare genetic …See details»
Unravel Biosciences, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Unravel Biosciences, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Unravel Biosciences - VentureRadar
The rapid integration between computation and experiments allows us to easily iterate the process to identify truly disease-modifying targets. The team of scientists behind Unravel Bio …See details»
Unravel Biosciences and JAX announce collaboration
Sep 16, 2024 Unravel's platform developed RVL002, a first-in-class new small molecule targeting mitochondrial metabolism, and RVL027, a molecule …See details»
Science — Unravel Biosciences
Unravel begins with patients, using their RNA to define each disease using unbiased molecular data to power our systems biology approach. BioNAV, our …See details»
Founder Spotlight #48: Richard Novak @ Unravel …
Mar 28, 2023 Prior to Unravel Bio, he was a Lead Engineer at the Wyss Institute for Biologically Inspired Engineering at Harvard University where he managed …See details»
About — rareSHIFT
Prior to Unravel Bio, he was a Lead Engineer at the Wyss Institute for Biologically Inspired Engineering at Harvard University where he managed fast-paced programs in drug discovery, …See details»
Unravel Biosciences - BIO International Convention | BIO
Jun 5, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Unravel …See details»
Unravel Biosciences - workinbiotech.com
Unravel Biosciences is unraveling the complexities of gene function and regulation to advance our understanding of human biology and disease. Integrating a high-throughput in vivo screening …See details»
Network – Fellows Bio – Richard Novak – The Termeer Foundation
The Termeer Foundation is a nonprofit organization working to vibrantly connect and empower the world of healthcare innovators until every patient has a cure. ... He co-founded Unravel …See details»
News - Unravel Biosciences
News @ Unravel Bio. 2025. Unravel Biosciences and COMBINED Brain Announce Large-Scale Drug Discovery Collaboration for Rare Neurological Diseases with High Unmet Need. …See details»
About - Unravel Biosciences
Prior to Unravel Bio, he was a Lead Engineer at the Wyss Institute for Biologically Inspired Engineering at Harvard University where he managed fast-paced programs in drug discovery, …See details»
rareSHIFT
Through a collaboration between Unravel Biosciences, orphan disorder foundations, and clinical research insitutions, we are creating a centralized public database of RNAseq data from rare …See details»
Portfolio — Unravel Biosciences
196 Boston Ave. Suite 1000. Medford, MA 02155. Menu. About Us. Science. Portfolio. Services. NewsSee details»
A Year in Review 2024 — Unravel Biosciences
Unravel is collaborating with Zymo Research Corporation and Channel Islands Marine & Wildlife Institute (CIMWI) to identify an injectable therapy for sea lions dying of domoic acid (DA) …See details»
Services — Unravel Biosciences
We “unravel” this complexity through our therapeutic mechanism stratification pipeline, finding drug responder groups within a complex population and finding other applications of …See details»
BIO 2025: Breakthroughs can't wait. | BIO - bio.org
1 day ago America’s leadership in biotech is essential to national security—and it’s under threat, said the National Security Commission on Emerging Biotechnology (NSCEB) in a BIO 2025 …See details»